Wei-Guo Ma1,2, Bulat A Ziganshin1,3, Chang-Fa Guo1,4, Mohammad A Zafar1, Richard S Sieller1, Maryann Tranquilli1, John A Elefteriades1. 1. Aortic Institute at Yale-New Haven Hospital, Yale University School of Medicine, New Haven, CT, USA. 2. Beijing Anzhen Hospital, Capital Medical University, Beijing 100029, China. 3. Department of Surgical Diseases #2, Kazan State Medical University, Kazan, Russia. 4. Zhongshan Hospital, Fudan University, Shanghai 200032, China.
Abstract
BACKGROUND: Although bovine serum albumin-glutaraldehyde glue (BioGlue®) has been successfully used as a hemostatic adjunct in aortic surgical procedures, there are reports that it may lead to anastomotic pseudoaneurysm formation. We seek to examine if the use of BioGlue is associated with a high incidence of anastomotic pseudoaneurysm formation following surgical repair of thoracic aortic disease. METHODS: We reviewed the medical records and follow-up computed tomography (CT) scans of patients from 2001 to 2015 in whom BioGlue was used during surgical repair of thoracic aortic disease to detect postoperative anastomotic pseudoaneurysm formation. RESULTS: A total of 233 patients with BioGlue use were identified. Mean age was 63.5±14.0 years (median 66; range 14-88; 25-75%, IQR 54-74 years) and 149 were male (63.9%). Surgical indication was thoracic aortic aneurysm in 169 (72.5%) patients, aortic dissection in 49 (21.0%), intramural hematoma in 9 (3.9%), penetrating aortic ulcer in 3 (1.3%) and other in 3 (1.3%). Emergency/urgent surgery was performed in 68 cases (29.2%). Operative mortality was 7.3% (17/233). Re-exploration for bleeding and neurologic deficits occurred in 24 (10.3%) and 21 (9.0%) patients respectively. All operative survivors were followed (100%, 216/216) and CT follow-up was available in 81.9% (177/216) for a mean duration of 2.4 years (median 0.6; 25-75% IQR 0.2-3.6 years). Anastomotic pseudoaneurysm was detected in 1 patient (0.6%) at 3 years postoperatively. This was an elderly female with extremely frail tissues who underwent a reoperative ascending and arch replacement for dissection. CONCLUSIONS: The use of BioGlue in thoracic aortic surgery was not associated with excess incidence of anastomotic pseudoaneurysm formation following surgical repair of thoracic aortic disease. Its use need not be discouraged on this basis.
BACKGROUND: Although bovine serum albumin-glutaraldehyde glue (BioGlue®) has been successfully used as a hemostatic adjunct in aortic surgical procedures, there are reports that it may lead to anastomotic pseudoaneurysm formation. We seek to examine if the use of BioGlue is associated with a high incidence of anastomotic pseudoaneurysm formation following surgical repair of thoracic aortic disease. METHODS: We reviewed the medical records and follow-up computed tomography (CT) scans of patients from 2001 to 2015 in whom BioGlue was used during surgical repair of thoracic aortic disease to detect postoperative anastomotic pseudoaneurysm formation. RESULTS: A total of 233 patients with BioGlue use were identified. Mean age was 63.5±14.0 years (median 66; range 14-88; 25-75%, IQR 54-74 years) and 149 were male (63.9%). Surgical indication was thoracic aortic aneurysm in 169 (72.5%) patients, aortic dissection in 49 (21.0%), intramural hematoma in 9 (3.9%), penetrating aortic ulcer in 3 (1.3%) and other in 3 (1.3%). Emergency/urgent surgery was performed in 68 cases (29.2%). Operative mortality was 7.3% (17/233). Re-exploration for bleeding and neurologic deficits occurred in 24 (10.3%) and 21 (9.0%) patients respectively. All operative survivors were followed (100%, 216/216) and CT follow-up was available in 81.9% (177/216) for a mean duration of 2.4 years (median 0.6; 25-75% IQR 0.2-3.6 years). Anastomotic pseudoaneurysm was detected in 1 patient (0.6%) at 3 years postoperatively. This was an elderly female with extremely frail tissues who underwent a reoperative ascending and arch replacement for dissection. CONCLUSIONS: The use of BioGlue in thoracic aortic surgery was not associated with excess incidence of anastomotic pseudoaneurysm formation following surgical repair of thoracic aortic disease. Its use need not be discouraged on this basis.
Authors: Scott A LeMaire; Susan Y Green; Kapil Sharma; Catherine K Cheung; Aryan Sameri; Peter I Tsai; Gerald Adams; Joseph S Coselli Journal: Ann Thorac Surg Date: 2009-02 Impact factor: 4.330
Authors: Bartosz Rylski; Joseph E Bavaria; Rita K Milewski; Prashanth Vallabhajosyula; William Moser; Emily Kremens; Alberto Pochettino; Wilson Y Szeto; Nimesh D Desai Journal: Ann Thorac Surg Date: 2014-06-10 Impact factor: 4.330
Authors: Joseph E Bavaria; Derek R Brinster; Robert C Gorman; Y Joseph Woo; Thomas Gleason; Alberto Pochettino Journal: Ann Thorac Surg Date: 2002-11 Impact factor: 4.330
Authors: Mark H Murdock; Jordan T Chang; Samuel K Luketich; Drake Pedersen; George S Hussey; Antonio D'Amore; Stephen F Badylak Journal: J Thorac Cardiovasc Surg Date: 2018-09-01 Impact factor: 5.209
Authors: Davide Pacini; Giacomo Murana; David Hollinworth; William F Northrup; Stacy G Arnold; Roberto Di Bartolomeo Journal: Front Surg Date: 2022-09-09